Skip to main content

LGND

Ligand Pharmaceuticals Inc

Company with tickers: LGND, LGNDZ, LGNXZ, LGNYZ, LGNZZ

CIK
886163
CUSIP
53220K504
Shares Outstanding
20,041,061
13F Activity (30d)
28 filings 5 filers
Price
$274.88
Market Cap
$5.51B
P/E Ratio
44.84
EPS (Diluted)
$6.13
52W High
$276.20
52W Low
$110.00

Daily candlestick prices with configurable technical indicators (moving averages, Bollinger Bands, RSI, MACD) and event bullets for 10-K, 10-Q, Form 4 and earnings dates. Price data syncs automatically from Yahoo Finance.

Latest guidance from the 8-K filed May 7, 2026
Metric Period Guided Actual
adjusted earnings per diluted share full-year 2026 $8.50 – $9.50
royalty revenue full-year 2026 $225M – $250M
Revenue from sales of Captisol full-year 2026 $35M – $40M
contract revenue full-year 2026 $10M – $20M
total revenue full-year 2026 $270M – $310M
2 Up Days

Price & Indicators

Drag to pan · scroll to zoom

Performance

5D 20D 120D MTD YTD
LGND +8.0% +26.2% +39.4% +18.5% +45.4%
SPY +1.2% +0.7% +8.2% -1.3% +9.5%
vs SPY +6.8% +25.5% +31.3% +19.8% +35.9%
Close
$274.88
Open
$267.06
Day Range
$265.88 — $276.20
52W High
$276.20
52W Low
$110.00
Avg Vol (30d)
210K
Short Interest
1.6M · 8.2d
Short Vol % (latest)
81%
Last Earnings
2026-05-07
Latest Filing
Data Range
2020-01-02 — 2026-06-18